Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Raymond

Showing results (161-170 of 214) with videos related to

Pageof 22
Sort By:
Advances in Experimental Medicine and Biology|January 10, 2004
Evaluation of the preventive effect of glyceryl trioleate-trierucate ("Lorenzo's oil") therapy in X-linked adrenoleukodystrophy: results of two concurrent trialsHugo W Moser, Gerald V Raymond, Wolfgang Koehler, et al.
Molecular Genetics and Metabolism|November 26, 2013
Newborn screening for X-linked adrenoleukodystrophy: further evidence high throughput screening is feasibleChristiane Theda, Katy Gibbons, Todd E Defor, et al.
Molecular Genetics and Metabolism|February 8, 2014
The Pex1-G844D mouse: a model for mild human Zellweger spectrum disorderShandi Hiebler, Tomohiro Masuda, Joseph G Hacia, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 8, 2018
Survival and Functional Outcomes in Boys with Cerebral Adrenoleukodystrophy with and without Hematopoietic Stem Cell TransplantationGerald V Raymond, Patrick Aubourg, Asif Paker, et al.
The Journal of Clinical Investigation|December 26, 2001
MPDU1 mutations underlie a novel human congenital disorder of glycosylation, designated type IfB Schenk, T Imbach, C G Frank, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|May 12, 2019
Biomarker Identification, Safety, and Efficacy of High-Dose Antioxidants for Adrenomyeloneuropathy: a Phase II Pilot StudyCarlos Casasnovas, Montserrat Ruiz, Agatha Schlüter, et al.
Neurology|May 30, 2002
Molecular findings in symptomatic and pre-symptomatic Alexander disease patientsJ R Gorospe, S Naidu, A B Johnson, et al.
American Journal of Human Genetics|May 7, 2002
Contiguous deletion of the X-linked adrenoleukodystrophy gene (ABCD1) and DXS1357E: a novel neonatal phenotype similar to peroxisomal biogenesis disordersDeyanira Corzo, William Gibson, Kisha Johnson, et al.
Molecular Genetics and Metabolism|March 1, 2015
Newborn screening for X-linked adrenoleukodystrophy in New York State: diagnostic protocol, surveillance protocol and treatment guidelinesB H Vogel, S E Bradley, D J Adams, et al.
The Cleft Palate-Craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association|November 5, 1997
Testing for interaction between maternal smoking and TGFA genotype among oral cleft cases born in Maryland 1992-1996T H Beaty, N E Maestri, J B Hetmanski, et al.
Pageof 22

Showing results (161-170 of 214) with videos related to

Sort By:
Pageof 22
Advances in Experimental Medicine and Biology|January 10, 2004
Evaluation of the preventive effect of glyceryl trioleate-trierucate ("Lorenzo's oil") therapy in X-linked adrenoleukodystrophy: results of two concurrent trialsHugo W Moser, Gerald V Raymond, Wolfgang Koehler, et al.
Molecular Genetics and Metabolism|November 26, 2013
Newborn screening for X-linked adrenoleukodystrophy: further evidence high throughput screening is feasibleChristiane Theda, Katy Gibbons, Todd E Defor, et al.
Molecular Genetics and Metabolism|February 8, 2014
The Pex1-G844D mouse: a model for mild human Zellweger spectrum disorderShandi Hiebler, Tomohiro Masuda, Joseph G Hacia, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 8, 2018
Survival and Functional Outcomes in Boys with Cerebral Adrenoleukodystrophy with and without Hematopoietic Stem Cell TransplantationGerald V Raymond, Patrick Aubourg, Asif Paker, et al.
The Journal of Clinical Investigation|December 26, 2001
MPDU1 mutations underlie a novel human congenital disorder of glycosylation, designated type IfB Schenk, T Imbach, C G Frank, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|May 12, 2019
Biomarker Identification, Safety, and Efficacy of High-Dose Antioxidants for Adrenomyeloneuropathy: a Phase II Pilot StudyCarlos Casasnovas, Montserrat Ruiz, Agatha Schlüter, et al.
Neurology|May 30, 2002
Molecular findings in symptomatic and pre-symptomatic Alexander disease patientsJ R Gorospe, S Naidu, A B Johnson, et al.
American Journal of Human Genetics|May 7, 2002
Contiguous deletion of the X-linked adrenoleukodystrophy gene (ABCD1) and DXS1357E: a novel neonatal phenotype similar to peroxisomal biogenesis disordersDeyanira Corzo, William Gibson, Kisha Johnson, et al.
Molecular Genetics and Metabolism|March 1, 2015
Newborn screening for X-linked adrenoleukodystrophy in New York State: diagnostic protocol, surveillance protocol and treatment guidelinesB H Vogel, S E Bradley, D J Adams, et al.
The Cleft Palate-Craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association|November 5, 1997
Testing for interaction between maternal smoking and TGFA genotype among oral cleft cases born in Maryland 1992-1996T H Beaty, N E Maestri, J B Hetmanski, et al.
Pageof 22